The9 Ltd
NCTY
BIT Mining
BTCM
FRMO CORP
FRMO
Digihost Technology
DGHI
Ebang International
EBON
US Stock MarketDetailed Quotes
ADPT Adaptive Biotechnologies
- 8.420
- 0.0000.00%
Trading Mar 26 10:14 ET
1.25BMarket Cap-7.80P/E (TTM)
8.537High8.290Low122.44KVolume8.420Open8.420Pre Close1.03MTurnover0.13%Turnover RatioLossP/E (Static)148.58MShares9.01052wk High6.17P/B812.33MFloat Cap2.28052wk Low--Dividend TTM96.48MShs Float71.250Historical High--Div YieldTTM2.93%Amplitude2.280Historical Low8.412Avg Price1Lot Size
Adaptive Biotechnologies News
Goldman Sachs Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Maintains Target Price $9
Adaptive Biotechnologies Analyst Ratings
Goldman Sachs Upgrades Adaptive Biotechnologies(ADPT.US) to Buy Rating, Raises Target Price to $9
Goldman Sachs Upgrades Adaptive Biotechnologies to Buy From Neutral, Adjusts Price Target to $9 From $8
BTIG Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Maintains Target Price $10
Adaptive Biotechnologies (ADPT) Gets a Buy From BTIG
Piper Sandler Sticks to Their Buy Rating for Adaptive Biotechnologies (ADPT)
Piper Sandler Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $11
BTIG Initiates Adaptive Biotechnologies(ADPT.US) With Buy Rating, Announces Target Price $10
Adaptive Biotechnologies Is Maintained at Sector Outperform by Scotiabank
Adaptive Biotechnologies Analyst Ratings
Scotiabank Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $12
Stable Performance and Strategic Guidance Support Hold Rating for Adaptive Biotechnologies
TD Cowen Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Announces Target Price $10
Analysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (ADPT) and Springworks Therapeutics (SWTX)
J.P. Morgan Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $8
Adaptive Biotechnologies Analyst Ratings
Goldman Sachs Maintains Neutral on Adaptive Biotechnologies, Raises Price Target to $7.5
Piper Sandler Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Maintains Target Price $7
Analysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (ADPT) and Teladoc (TDOC)
Market Insights
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
